Botanix Pharmaceuticals Ltd has released a press release.
Quarterly Cashflow Report
Filed with ASX ·
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Botanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Botanix Announces Positive Human Trial Data
- Botanix Accelerates Clinical Program with First Human Study
- DEA Scheduling Decision Supports Botanix Approach
- Botanix Secures Commercial-Scale Synthetic Cannabidiol
- Reinstatement to Official Quotation - 15 July 2016
Later from Botanix Pharmaceuticals
- Botanix Announces Expansion of Permetrex License
- Botanix Announces Filing of New Permetrex Product Patents
- Export and Import Approvals for Clinical Studies Received
- Botanix Receives Approval for Synthetic Cannabidiol Trial
- Suspension from Official Quotation
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals